amantadine has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 3 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "L-Carnitine is a safe and very well tolerated medicine which improves the clinical status of CFS patients." | 2.68 | Amantadine and L-carnitine treatment of Chronic Fatigue Syndrome. ( Plioplys, AV; Plioplys, S, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Plioplys, AV | 1 |
| Plioplys, S | 1 |
| Bowman, MA | 1 |
| Kirk, JK | 1 |
| Michielutte, R | 1 |
| Preisser, JS | 1 |
| Wiggs, JW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Estudio clínico Fase III Para Evaluar la Eficacia terapéutica en Pacientes Mexicanos Con Dislipidemia Mediante el Uso vía Oral de L-Carnitina + Atorvastatina Comparado Con Atorvastatina[NCT03696940] | Phase 3 | 120 participants (Actual) | Interventional | 2018-05-28 | Active, not recruiting | ||
| A Randomised, Double Blinded Cross-over Study Comparing the Efficacy of L-carnitine Versus Placebo in the Treatment of Fatigue in Multiple Sclerosis[NCT01149525] | Phase 3 | 59 participants (Actual) | Interventional | 2010-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for amantadine and Chronic Fatigue and Immune Dysfunction Syndrome
| Article | Year |
|---|---|
Amantadine and L-carnitine treatment of Chronic Fatigue Syndrome.
Topics: Amantadine; Antiviral Agents; Carnitine; Cross-Over Studies; Fatigue Syndrome, Chronic; Humans; Neur | 1997 |
Amantadine and L-carnitine treatment of Chronic Fatigue Syndrome.
Topics: Amantadine; Antiviral Agents; Carnitine; Cross-Over Studies; Fatigue Syndrome, Chronic; Humans; Neur | 1997 |
Amantadine and L-carnitine treatment of Chronic Fatigue Syndrome.
Topics: Amantadine; Antiviral Agents; Carnitine; Cross-Over Studies; Fatigue Syndrome, Chronic; Humans; Neur | 1997 |
Amantadine and L-carnitine treatment of Chronic Fatigue Syndrome.
Topics: Amantadine; Antiviral Agents; Carnitine; Cross-Over Studies; Fatigue Syndrome, Chronic; Humans; Neur | 1997 |
Use of amantadine for chronic fatigue syndrome.
Topics: Adult; Amantadine; Antidepressive Agents; Cross-Over Studies; Fatigue Syndrome, Chronic; Female; Hum | 1997 |
1 other study available for amantadine and Chronic Fatigue and Immune Dysfunction Syndrome
| Article | Year |
|---|---|
Amantidine, the old anti-Parkinson medication, being useful in the fatigue syndrome that often accompanies multiple sclerosis.
Topics: Amantadine; Fatigue; Fatigue Syndrome, Chronic; Humans; Male; Middle Aged; Multiple Sclerosis; Parki | 1991 |